FUSITAB

Oxford BioMedica plc

Application Filed: 2000-10-16

Trademark Application Details

Mark For: FUSITAB® trademark registration is intended to cover the categories of gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems.

Status

2021-07-25 UTC

DEAD REGISTRATION Cancelled Invalidated

The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.

Research	OneLook Acronym Finder
Serial Number	78030862
Registration Number	2747063
Mark Literal Elements	FUSITAB
Mark Drawing Type	1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark Type	Trademark, Service Mark
Standard Character Claim	No
Current Location	SCANNING ON DEMAND 2008-06-10
Basis	44(e)
Class Status	SECTION 8 - CANCEL
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	No
Filed ITU	Yes
44D Filed	Yes
44E Current	Yes
66A Current	No
Current Basis	No
No Basis	No
Cancellation Code	2
Domestic Representative	Scott K. Haight
Attorney Name	Scott K. Haight
Attorney Docket Number	50096.0000
Law Office Assigned	M10
Employee Name	PERKINS, ELLEN J

Timeline

2000-10-16	Application Filed
2002-07-02	Published
2002-07-02	Published for Opposition
2003-08-05	Trademark Registered
2008-06-10	Location: SCANNING ON DEMAND
2010-03-07	Cancelled
2010-03-07	Status: Dead/Cancelled
2010-03-07	Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	Oxford BioMedica plc
Address	Medawar Centre Robert Robinson Avenue The Oxford Science Park Oxford UNITED KINGDOM OX4 4GA
Legal Entity Type	Company
Legal Entity State	UNITED KINGDOM

Documents

Application	TIFF	2000-10-16
Drawing	TIFF	2000-10-16
Paper Correspondence Incoming	TIFF	2002-10-04
Paper Correspondence Incoming	TIFF	2002-11-01
Paper Correspondence Incoming	TIFF	2002-11-04
Change of Address	IMAGE/TIFF	2002-11-25
Registration Certificate	TIFF	2003-08-05
Registration Certificate	TIFF	2003-08-05
File Jacket	JPEG	2008-06-04
Unclassified	MULTI	2008-06-04

Attorney of Record

Scott K. Haight
Butler, Snow, O'Mara, Stevens & Cannada
P.O. Box 171443
Memphis TN 38187-1443

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	10
U.S. Codes:	026,039,044
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems

Type Code

Type

GS0051

Gene therapy and prophylaxis products, namely, clinical, medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents/nucleic acid/antibodies for gene therapy; vaccines; enzymes and enzyme preparations for medical purposes, namely, gene therapy for use in the treatment of viral and bacterial infections, cancer and bodily conditions associated with immunosystems

Trademark Filing History

Description	Date	Proceeding Number
CANCELLED SEC. 8 (6-YR)	2010-03-07
CASE FILE IN TICRS	2008-06-10
REGISTERED-PRINCIPAL REGISTER	2003-08-05
Sec. 1(B) CLAIM DELETED	2003-06-09	61756
NOTICE OF ALLOWANCE CANCELLED	2003-03-24
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2002-11-25
PAPER RECEIVED	2002-11-04
PAPER RECEIVED	2002-10-04
NOA MAILED - SOU REQUIRED FROM APPLICANT	2002-09-24
PUBLISHED FOR OPPOSITION	2002-07-02
NOTICE OF PUBLICATION	2002-06-12
APPROVED FOR PUB - PRINCIPAL REGISTER	2002-03-09
CORRESPONDENCE RECEIVED IN LAW OFFICE	2002-02-04
LETTER OF SUSPENSION MAILED	2001-11-07
ASSIGNED TO EXAMINER	2001-11-07	78328
CORRESPONDENCE RECEIVED IN LAW OFFICE	2001-10-01
NON-FINAL ACTION MAILED	2001-03-29
ASSIGNED TO EXAMINER	2001-03-22	76507

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.